HMR1964

HMR1964 · Sanofi

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HMR1964, covering 2008-06-19 to 2008-06-19. Get the full timeline:

Most recent: Clinical Trial Update: 12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes. [Phase 3]

See pricing